<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Mitchell, T.J.</title>
    <link>http://repub.eur.nl/res/aut/11195/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins (Letter To Editor)</title>
      <link>http://repub.eur.nl/res/pub/25521/</link>
      <pubDate>2011-04-01T00:00:00Z</pubDate>
      <description>Presently, several pneumococcal proteins are being evaluated as potential vaccine candidates. Here, we gather novel insights in the immunogenicity of PLY, PsaA, PspA, PspC, NanA, Hyl, PpmA, SlrA, Eno, IgA1-protease, PdBD, BVH-3, SP1003, SP1633, SP1651, SP0189 and SP0376. We developed a multiplex bead-based immunoassay (xMAP® Technology, Luminex Corporation) to simultaneously quantify antibodies against these 17 pneumococcal proteins in serum. The median fluorescence intensity (MFI) values obtained for human pooled serum with the multiplex assay were between 82% and 111% (median 94%) of those obtained with the singleplex assays. For IgG, the coefficient of variation (CV) in serum ranged from 2% to 9%, for IgA, the CV ranged from 3% to 14% and for IgM, the CV ranged from 11% to 15%. Using this immunoassay, we showed that anti-pneumococcal antibody levels exhibited extensive inter-individual variability in young children suffering from invasive pneumococcal disease. All proteins, including the proteins with, as yet, unknown function, were immunogenic. In conclusion, the multiplex Streptococcus pneumoniae immunoassay based on proteins is reproducible. This assay can be used to monitor anti-S. pneumoniae antibody responses in a material- and time-saving manner. </description>
    </item> <item>
      <title>Regulation of gene expression in Streptococcus pneumoniae by response regulator 09 is strain dependent (Article)</title>
      <link>http://repub.eur.nl/res/pub/35581/</link>
      <pubDate>2007-02-01T00:00:00Z</pubDate>
      <description>Recent murine studies have demonstrated that the role of response regulator 09 (RR09) of Streptococcus pneumoniae in virulence is different in different strains. In the present study, we used a murine pneumonia model of infection to assess the virulence of a TIGR4 rr09 mutant, and we found that TIGR4Δrr09 was attenuated after intranasal infection. Furthermore, we investigated the in vitro transcriptional changes in pneumococcal rr09 mutants of two strains, D39 and TIGR4, by microarray analysis. The transcriptional profiles of the rr09 mutants of both strains had clear differences compared to the profiles of the parental wild-type strains. In D39Δrr09, but not in TIGR4Δrr09, genes involved in competence (e.g., comAB) were upregulated. In TIGR4, genes located on the rlrA pathogenicity islet, which are not present in the D39 genome, appeared to be regulated by RR09. Furthermore, several phosphotransferase systems (PTSs) believed to be involved in sugar uptake (e.g., the PTS encoded by sp0060 to sp0066) were strongly downregulated in D39Δrr09, while they were not regulated by RR09 in TIGR4. To examine the role of one of these PTSs in virulence, D39Δsp0063 was constructed and tested in a murine infection model. No difference between the virulence of this strain and the virulence of the wild type was found, indicating that downregulation of the sp0063 gene alone is not the cause of the avirulent phenotype of D39Δrr09. Finally, expression of rr09 and expression of three of our identified RR09 targets during infection in mice were assessed. This in vivo experiment confirmed that there were differences between expression in wild-type strain TIGR4 and expression in the rr09 mutant, as well as differences between expression in wild-type strain D39 and expression in wild-type strain TIGR4. In conclusion, our results indicate that there is strain-specific regulation of pneumococcal gene expression by RR09. Copyright </description>
    </item> <item>
      <title>Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13628/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>A randomized double-blind trial with a 7-valent pneumococcal conjugate vaccine was conducted in The Netherlands among 383 children, aged 1 to 7 years, with a history of recurrent acute otitis media. No effect of vaccination on the pneumococcal colonization rate was found. However, a shift in serotype distribution was clearly observed (R. Veenhoven et al., Lancet 361:2189-2195, 2003). We investigated the molecular epidemiology of 921 pneumococcal isolates retrieved from both the pneumococcal vaccine (PV) and control vaccine (CV) groups during the vaccination study. Within individuals a high turnover rate of pneumococcal restriction fragment end labeling genotypes, which was unaffected by vaccination, was observed. Comparison of the genetic structures before and after completion of the vaccination scheme revealed that, despite a shift in serotypes, there was clustering of 70% of the pneumococcal populations. The remaining isolates (30%) were equally observed in the PV and CV groups. In addition, the degree of genetic clustering was unaffected by vaccination. However, within the population genetic structure, nonvaccine serotype clusters with the serotypes 11, 15, and 23B became predominant over vaccine-type clusters after vaccination. Finally, overall pneumococcal resistance was low (14%), and, albeit not significant, a reduction in pneumococcal resistance as a result of pneumococcal vaccination was observed. Molecular surveillance of colonization in Dutch children shows no effect of pneumococcal conjugate vaccination on the degree of genetic clustering and the genetic structure of the pneumococcal population. However, within the genetic pneumococcal population structure, a clear shift toward nonvaccine serotype clusters was observed.</description>
    </item> <item>
      <title>Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children (Article)</title>
      <link>http://repub.eur.nl/res/pub/10272/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>A total of 128 Streptococcus pneumoniae isolates that were susceptible to
      penicillin but resistant to non-beta-lactam agents were isolated from
      young carriers in Greece and analyzed by antibiotic susceptibility
      testing, serotyping, restriction fragment end labeling (RFEL), and
      antibiotic resistance genotyping. The serotypes 6A/B (49%), 14 (14%),
      19A/F (11%), 11A (9%), 23A/F (4%), 15B/C (2%), and 21 (2%) were most
      prevalent in this collection. Of the isolates, 65% were erythromycin
      resistant, while the remaining isolates were tetracycline and/or
      trimethoprim-sulfamethoxazole resistant. Fifty-nine distinct RFEL types
      were identified. Twenty different RFEL clusters, harboring 2 to 19 strains
      each, accounted for 76% of all strains. Confirmatory multilocus sequence
      typing analysis of the genetic clusters showed the presence of three
      international clones (Tennessee(23F)-4, England(14)-9, and Greece(6B)-22)
      representing 30% of the isolates. The erm(B) gene was present in 70% of
      the erythromycin-resistant isolates, whereas 18 and 8% contained the
      mef(A) and mef(E) genes, respectively. The pneumococci representing
      erm(B), erm(A), and mef genes belonged to distinct genetic clusters. In
      total, 45% of all isolates were tetracycline resistant. Ninety-six percent
      of these isolates contained the tet(M) gene. In conclusion,
      penicillin-susceptible pneumococci resistant to non-beta-lactams are a
      genetically heterogeneous group displaying a variety of genotypes,
      resistance markers, and serotypes. This suggests that multiple genetic
      events lead to non-beta-lactam-resistant pneumococci in Greece.
      Importantly, most of these genotypes are capable of disseminating within
      the community.</description>
    </item> <item>
      <title>The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses (Article)</title>
      <link>http://repub.eur.nl/res/pub/9386/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Surface-exposed proteins often play an important role in the interaction
          between pathogenic bacteria and their host. We isolated a pool of
          hydrophobic, surface-associated proteins of Streptococcus pneumoniae. The
          opsonophagocytic activity of hyperimmune serum raised against this protein
          fraction was high and species specific. Moreover, the opsonophagocytic
          activity was independent of the capsular type and chromosomal genotype of
          the pneumococcus. Since the opsonophagocytic activity is presumed to
          correlate with in vivo protection, these data indicate that the protein
          fraction has the potential to elicit species-specific immune protection
          with cross-protection against various pneumococcal strains. Individual
          proteins in the extract were purified by two-dimensional gel
          electrophoresis. Antibodies raised against three distinct proteins
          contributed to the opsonophagocytic activity of the serum. The proteins
          were identified by mass spectrometry and N-terminal amino acid sequencing.
          Two proteins were the previously characterized pneumococcal surface
          protein A and oligopeptide-binding lipoprotein AmiA. The third protein was
          the recently identified putative proteinase maturation protein A (PpmA),
          which showed homology to members of the family of peptidyl-prolyl
          cis/trans isomerases. Immunoelectron microscopy demonstrated that PpmA was
          associated with the pneumococcal surface. In addition, PpmA was shown to
          elicit species-specific opsonophagocytic antibodies that were
          cross-reactive with various pneumococcal strains. This antibody
          cross-reactivity was in line with the limited sequence variation of ppmA.
          The importance of PpmA in pneumococcal pathogenesis was demonstrated in a
          mouse pneumonia model. Pneumococcal ppmA-deficient mutants showed reduced
          virulence. The properties of PpmA reported here indicate its potential for
          inclusion in multicomponent protein vaccines.</description>
    </item>
  </channel>
</rss>